IP Library › Granted Patent US 12,274,668
Granted Patent B2
US 12,274,668 · App. 18/669,727 · Granted Apr 15, 2025

Needle assemblies containing oriented needles and methods for production thereof

Inventors: Hyun Cho (Berkeley, CA); Yi Wang (San Ramon, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61H39/086A61B5/6848B29C45/14065B29C45/14598A61H2230/20B29C2045/0089B29C2045/14131B29C2045/14327B29L2031/759
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,274,668
App. No.
18/669,727
Granted
Apr 15, 2025
Kind
B2
Abstract

Acupuncture needles may be used for piercing tissue with less trauma than may occur when employing larger gauge needles. However, because acupuncture needles are fabricated and packaged differently than are larger gauge needles, acupuncture needles may be less compatible with certain manufacturing processes. Needle assemblies compatible with manufacturing processes may comprise a continuous support material having a plurality of apertures defined therein, and a first injection molded coupler that surrounds a proximal portion of an acupuncture needle and connects the acupuncture needle to a first location upon the continuous support material, such that the acupuncture needle is held in a pre-determined orientation with respect to a longitudinal axis of the first injection molded coupler. The acupuncture needles in adjacent apertures may also be spaced apart substantially uniformly.

Claims (12)

1. An inserter for an analyte monitoring system, comprising:

a needle hub comprising an injection molded piece surrounding a needle, wherein the needle is oriented non-parallel with respect to a longitudinal axis of the injection molded piece, and wherein the injection molded piece comprises a metal core that is coincident with the longitudinal axis; and

an analyte sensor, wherein a portion of the analyte sensor is configured to be inserted under the skin of a subject.

2. The inserter of claim 1 , wherein a proximal portion of the needle is bent.

3. The inserter of claim 1 , wherein a proximal portion of the needle contains a pinch point.

4. The inserter of claim 1 , wherein a proximal portion of the needle contains a combination of a bent and a pinch point.

5. The inserter of claim 1 , wherein the needle ranges between about 0.1 mm and about 0.6 mm in diameter.

6. The inserter of claim 1 , wherein a portion of the needle extending from the injection molded piece is held non-parallel with respect to the longitudinal axis of the injection molded piece.

7. The inserter of claim 6 , wherein the portion of the needle extending from the injection molded piece is held at an angle ranging between about 5° and about 15° with respect to the longitudinal axis.

8. The inserter of claim 1 , wherein the analyte sensor monitors an analyte selected from the group consisting of glucose, lactate, and ketones.

9. The inserter of claim 1 , wherein the analyte sensor comprises three electrodes.

10. The inserter of claim 1 , wherein the needle is an acupuncture needle.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 23, 2024
From: CHO, HYUN; WANG, YI
To: ABBOTT DIABETES CARE INC.
Reel/Frame 067508/0607 →
Continuity (3)
Continuation 17269595
Provisional Application 62721711 · Aug 23, 2018
Related Publication 20240366470A1 · Nov 7, 2024
References Cited (48)
US 3768635A · Eggert · 1973 [cited by applicant]
US 4488393A · Dinh Can · 1984 [cited by applicant]
US 6231584B1 · Gavronsky · 2001 [cited by applicant]
US 8226540B1 · Chi · 2012 [cited by applicant]
US 9186098B2 · Lee et al. · 2015 [cited by applicant]
US 9402570B2 · Pace et al. · 2016 [cited by applicant]
US 10674944B2 · Pace · 2020 [cited by applicant]
US 20050021067A1 · Kim · 2005 [cited by applicant]
US 20060173478A1 · Schraga · 2006 [cited by applicant]
US 20110213225A1 · Bernstein et al. · 2011 [cited by applicant]
US 20140171771A1 · Feldman et al. · 2014 [cited by applicant]
US 20150352007A1 · Shayle · 2015 [cited by applicant]
US 20160008028A9 · Matsumoto et al. · 2016 [cited by applicant]
US 20160331283A1 · Rao et al. · 2016 [cited by applicant]
US 20160331284A1 · Rao et al. · 2016 [cited by applicant]
US 20170196487A1 · Feldman et al. · 2017 [cited by applicant]
US 20180235520A1 · Rao et al. · 2018 [cited by applicant]
US 20190282137A1 · Stafford · 2019 [cited by applicant]
US 20190347086A1 · Kiaie et al. · 2019 [cited by applicant]
US 20200196919A1 · Rao et al. · 2020 [cited by applicant]
US 20210219887A1 · Yee et al. · 2021 [cited by applicant]
US 20220183595A1 · Wang et al. · 2022 [cited by applicant]
CN 2277259Y · 1998 [cited by applicant]
CN 201058116Y · 2008 [cited by applicant]
CN 201295380Y · 2009 [cited by applicant]
CN 202096441U · 2012 [cited by applicant]
CN 104721042A · 2015 [cited by applicant]
EP 3766408A1 · 2021 [cited by applicant]
JP 8173504A · 1996 [cited by applicant]
JP 2003116962A · 2003 [cited by applicant]
JP 2013066531A · 2013 [cited by applicant]
JP 2013166363A · 2013 [cited by applicant]
JP 2018021811A · 2018 [cited by applicant]
WO WO0158348A2 · 2001 [cited by applicant]
WO WO2013100057A1 · 2013 [cited by applicant]
WO WO2013144255A1 · 2013 [cited by applicant]
WO WO2014111681A2 · 2014 [cited by applicant]
WO WO2018136898A1 · 2018 [cited by applicant]
WO WO2019236850A1 · 2019 [cited by applicant]
WO WO2019236859A1 · 2019 [cited by applicant]
WO WO2019236876A1 · 2019 [cited by applicant]
WO WO2020041571A1 · 2020 [cited by applicant]
JP, 2023-094274 Final Office Action, Sep. 10, 2024. [cited by applicant]
CA, 3,107,791 Examiner's Report, Jan. 11, 2022. [cited by applicant]
CN, 201980055443.1 First Office Action, Jan. 30, 2024. [cited by applicant]
JP, 2023-094274 Office Action, Mar. 26, 2024. [cited by applicant]
EP, 19763147.6 Examination Report, Dec. 21, 2023. [cited by applicant]
WO, PCT/US2019/047668 ISR and Written Opinion, Apr. 3, 2020. [cited by applicant]